SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the December 2022 quarter is pegged at Rs. 21614.71 millions, about 6.32% up against Rs. 20330.54 millions recorded during the year-ago period.Net profit declined -21.52% to Rs. 4305.03 millions from Rs. 5485.19 millions.The company reported a degrowth in operating Profit to 5285.67 millions from 7272.25 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 21614.71 20330.54 6.32 62816.13 63560.37 -1.17 81415.81 75679.33 7.58
Other Income 897.28 2167.43 -58.60 7529.74 4356.47 72.84 6146.28 3962.37 55.12
PBIDT 5285.67 7272.25 -27.32 20080.67 19622.83 2.33 23028.49 22865.78 0.71
Interest 557.24 497.72 11.96 1479.56 1620.32 -8.69 2360.41 2658.98 -11.23
PBDT 6353.47 6774.53 -6.22 20226.15 22305.84 -9.32 24971.41 20945.72 19.22
Depreciation 462.20 407.98 13.29 1374.19 1179.23 16.53 1596.95 1508.15 5.89
PBT 5891.27 6366.55 -7.47 18851.96 21126.61 -10.77 23374.46 19437.57 20.25
TAX 1586.24 881.36 79.98 5389.61 3204.69 68.18 3396.57 2943.10 15.41
Deferred Tax 550.87 -525.12 -204.90 2366.84 -503.44 -570.13 -714.21 -493.08 44.85
PAT 4305.03 5485.19 -21.52 13462.35 17921.92 -24.88 19977.89 16494.47 21.12
Equity 282.17 282.17 0.00 282.17 282.17 0.00 282.17 282.17 0.00
PBIDTM(%) 24.45 35.77 -31.64 31.97 30.87 3.55 28.29 30.21 -6.38

Glenmark Pharma Share Price

2364.35 -6.70 (-0.28%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×